Sugar Editorial Picks
Jun 04, 2008 -
Since the diagnosis of her son, Evan Asher, Jenny McCarthy has singled out autism as her cause. Today, the advocate and her boyfriend, actor Jim Carrey will lead the Green Our Vaccines march and rally in Washington, DC Like many other parents, the celeb mama has been very vocal and firm in her belief that there is a link between autism and vaccinations and continues to campaign for more research. The host-turned-playmate-turned-activist penned, Louder Than Words: A Mother's Journey in Healing Autism, a book about her experience helping her six-year-old to overcome his symptoms.
- 24 Comments
Other Search Results
Jun 04, 2008 -
Jim Carrey, Jenny McCarthy and little Evan were front and center in Washington, DC today for the Green Our Vaccines march. The loving couple and their adorable boy were out to support the cause which campaigns for further research into possible correlations between vaccines and autism, something near to their hearts since Evan was diagnosed with the developmental disorder. At the rally Jim spoke:
- On Evan: "He taught me how to love.
- 49 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Complications
- Risk Factors
- Prevention
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccine News:
- On September 28, 2007, the U.S. Food and Drug Administration (FDA) approved a new brand of inactivated influenza ("flu") vaccine, Alfuria, for adults aged 18 years or older. This vaccine is given by injection.
- On September 19, 2007, the FDA approved the use of the live flu vaccine (FluMist) in healthy children as young as 2 years of age.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Hepatitis A
- Hepatitis B and D
- Hepatitis C
- Autoimmune Hepatitis
- Symptom Management
- Outlook
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2006, the FDA approved telbivudine (Tyzeka), a new type of nucleoside analog drug, for treatment of chronic hepatitis B. There are now six drugs approved for hepatitis B treatment.
- In 2007, the FDA approved HepaGam B, an intravenous immune globulin drug, for preventing hepatitis B recurrence following liver transplantation.
Drug Warning
In 2007, the FDA revised the prescribing label for entecavir (Baraclude), a drug used to treat hepatitis B. The new label advises against using entacavir in patients infected with both hepatitis B and HIV who are not receiving antiretroviral (anti-HIV) therapy.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Prevention
- Diagnosis
- Treatment for Cervical Intr...
- Treatment for Cervical Canc...
- Treatment for Invasive Cerv...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Human Papilloma Virus (HPV) Prevalence
About 25% of women age 14 - 59 are infected with the human papilloma virus (HPV), indicates a 2007 study in the Journal of the American Medical Association (JAMA). HPV prevalence is highest (45%) among women age 20 - 24. HPV is the main cause of cervical cancer.
- 1 Comment
Oct 08, 2008 -
Overview
- What Causes It?
- Who's Most At Risk?
- Signs and Symptoms
- What to Expect at Your Provider's Office
- Treatment Options
- Prognosis/Possible Complications
- Special Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Rubella, also known as German measles or three-day measles, is a contagious viral infection. Before a rubella vaccine became available in 1969, outbreaks of the disease occured every 6 - 9 years. Now rubella is rare in locations where vaccination is standard practice.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Melanoma
- Nonmelanoma Skin Cancer
- Precancerous Skin Condition...
- Causes
- Risk Factors
- Prevention
- Screening
- Diagnosis
- Staging
- Treatment for Melanoma
- Treatment for Nonmelanoma S...
- Prognosis
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Risk factors
According to a report in the Archives of Dermatology, marathon runners are more likely than the general population to develop skin changes that increase the risk for melanoma.
Prevention
A study published in The Lancet indicates that the best ways to avoid sun damage are to reduce the time you spend in the sun and to wear a hat and clothing to protect as much of your skin as possible. Fabrics that are thick and tightly woven offer the best protection.
- 0 Comments
Sep 04, 2008 -
Overview
- Definition
- Alternative Names
- Causes, incidence, and risk factors
- Symptoms
- Signs and tests
- Treatment
- Expectations (prognosis)
- Complications
- Calling your health care provider
- Prevention
- References
Illustrations
Chickenpox - lesions on the chest
Chickenpox - lesion on the leg
Chickenpox
Chickenpox, acute pneumonia - chest X-ray
Chickenpox - close-up
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Chickenpox is one of the classic childhood diseases, and one of the most contagious. The affected child or adult may develop hundreds of itchy, fluid-filled blisters that burst and form crusts. Chickenpox is caused by a virus.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Other Treatments
- Decongestants
- Antihistamines
- Corticosteroids
- Immunotherapy
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Ciclesonide (Omanaris), a corticosteroid nasal spray, has been approved for treatment of seasonal and perennial allergic rhinitis (hay fever) in adults and children age 12 years and older.
FDA Drug Warnings
- The antihistamine promethazine (Phenergan) should not be given to children younger than age 2 because it may cause serious breathing problems.
- Omalizumab (Xolair) may cause a life-threatening allergic reaction (anaphylaxis). This drug is used to treat allergy-related asthma, but is also being investigated as an allergy treatment.
Cough and Cold Medicines for Children
In 2007, the FDA began reviewing the safety and effectiveness of cough and cold medicines for children.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Prevention
- Treatment for Acute Sinusit...
- Treatment for Chronic Sinus...
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Restriction
In February 2007, the FDA announced that the antibiotic telithromycin (Ketek) should no longer be used for treatment of acute bacterial sinusitis. In June 2006, the FDA reported that several people had died of liver damage after taking this drug. Telithromycin is now only approved for treatment of community-acquired pneumonia.
- 0 Comments